Stock Events

Stock Events

NEUROTECH INTL LTD ORD 

$0
2
-$0-0% Thursday 20:00

Statistics

Day High
-
Day Low
-
52W High
0
52W Low
0
Volume
-
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26FebExpected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.45
-0.3
-0.15
-0
Expected EPS
N/A
Actual EPS
-0.0467075

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-13.65MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NTILF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Anavex Life Sciences
AVXL
Mkt Cap684.57M
Anavex Life Sciences Corp. focuses on developing treatments for neurological disorders, similar to NTI's focus on neurology and brain health.
Axon Enterprise
AXON
Mkt Cap57.48B
Axon Neuroscience SE engages in the development of therapeutics for neurodegenerative diseases, directly competing in NTI's market space.
Biogen
BIIB
Mkt Cap22.63B
Biogen Inc. specializes in therapies for neurological diseases, aligning closely with NTI's focus on neurotherapeutic products.
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Ionis Pharmaceuticals, Inc. develops RNA-targeted therapies, including treatments for neurological diseases, competing with NTI's research and products.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company has a strong portfolio in neurodegenerative treatments, making it a direct competitor in the neurological sector.
Novartis
NVS
Mkt Cap237.61B
Novartis AG offers several products for neurological conditions, competing in the same therapeutic area as NTI.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. has a diversified portfolio that includes treatments for neurological disorders, positioning it as a competitor to NTI.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG develops various neurology-focused therapies, directly competing with NTI's product range.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals Incorporated works on advanced treatments for several diseases, including neurological disorders, competing with NTI.

About

Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company focuses on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Melbourne, Australia.
Show more...
CEO
Dr. Anthony Filippis M.B.A., Ph.D.
Country
AU

Listings

AU
AU
NTI.AU

0 Comments

Share your thoughts

FAQ

What is NEUROTECH INTL LTD ORD stock price today?▼
The current price of NTILF is $0 USD — it has decreased by -0% in the past 24 hours. Watch NEUROTECH INTL LTD ORD stock price performance more closely on the chart.
What is NEUROTECH INTL LTD ORD stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NEUROTECH INTL LTD ORD stocks are traded under the ticker NTILF.
When is the next NEUROTECH INTL LTD ORD earnings date?▼
NEUROTECH INTL LTD ORD is going to release the next earnings report on September 02, 2026.
What were NEUROTECH INTL LTD ORD earnings last quarter?▼
NTILF earnings for the last quarter are -0.05 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NEUROTECH INTL LTD ORD revenue for the last year?▼
NEUROTECH INTL LTD ORD revenue for the last year amounts to 0 USD.
What is NEUROTECH INTL LTD ORD net income for the last year?▼
NTILF net income for the last year is -13.65M USD.
In which sector is NEUROTECH INTL LTD ORD located?▼
NEUROTECH INTL LTD ORD operates in the Health Care sector.
When did NEUROTECH INTL LTD ORD complete a stock split?▼
NEUROTECH INTL LTD ORD has not had any recent stock splits.
Where is NEUROTECH INTL LTD ORD headquartered?▼
NEUROTECH INTL LTD ORD is headquartered in Melbourne, AU.